Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies

Allogeneic haploidentical HSCT (haplo-HSCT) and unrelated umbilical cord blood transplantation(UCBT)are used in patients lacking HLA-identical sibling or unrelated donors. With myeloablative condition and GVHD prophylaxis of using low-dose ATG and post-transplantation cyclophosphamide (PTCY), we con...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hua, Li, Xiaofan, Chen, Yiling, Li, Duihong, Chen, Xianling, Zhu, Zhijuan, Wang, Yiting, Huang, Jiafu, Chen, Ping, Chen, Yuanzhong, Li, Nainong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599442/
https://www.ncbi.nlm.nih.gov/pubmed/34804017
http://dx.doi.org/10.3389/fimmu.2021.733326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599442/
https://www.ncbi.nlm.nih.gov/pubmed/34804017
http://dx.doi.org/10.3389/fimmu.2021.733326

Ejemplares similares